• Myomo forecasts 2026 revenue of $46 million to $47 million.
• Expected cash burn totals less than $2 million in the second half of 2026.
• Third-quarter revenue rose 22% to $12.33 million, providing a base for the full-year outlook.
• Longer-term goals include annual revenue exceeding $100 million with a 70% gross margin.
• The longer-term outlook also targets positive EBITDA and cash flow, supported by expanded reimbursement access and new products.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myomo Inc. published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.